ArticleBlood advances2026

Real-world safety and effectiveness of zanubrutinib vs ibrutinib in CLL: the CLL-ZANU2024 Italian cohort.

Enrica Antonia Martino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.